Wedbush analyst Laura Chico maintained a Buy rating on Ovid Therapeutics (OVID – Research Report) today and set a price target of $4.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback